Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Lenz

Showing results (71-80 of 250) with videos related to

Pageof 25
Sort By:
Nature Human Behaviour|June 23, 2022
Large but diminishing effects of climate action nudges under rising costsSebastian Berger, Andreas Kilchenmann, Oliver Lenz, et al.
Journal of the American Chemical Society|October 31, 2025
NRVS Spectroscopy Resolves Distinct Bridging Hydride Intermediates in [NiFe]-HydrogenaseGiorgio Caserta, Konstantin Laun, Jean-Pierre Oudsen, et al.
FEBS Letters|August 3, 2005
A model system for [NiFe] hydrogenase maturation studies: Purification of an active site-containing hydrogenase large subunit without small subunitGordon Winter, Thorsten Buhrke, Oliver Lenz, et al.
The Journal of Biological Chemistry|November 8, 2008
Oxygen-tolerant H2 oxidation by membrane-bound [NiFe] hydrogenases of ralstonia species. Coping with low level H2 in airMarcus Ludwig, James A Cracknell, Kylie A Vincent, et al.
Journal of the American College of Surgeons|August 5, 2009
Secondary autogenous arteriovenous fistulas in the "fistula first" era: results of a longterm prospective studyLoay Salman, Manju Alex, Stephen W Unger, et al.
Journal of the American Chemical Society|February 4, 2015
Reversible active site sulfoxygenation can explain the oxygen tolerance of a NAD+-reducing [NiFe] hydrogenase and its unusual infrared spectroscopic propertiesMarius Horch, Lars Lauterbach, Maria Andrea Mroginski, et al.
The New England Journal of Medicine|March 5, 2004
Sequential therapies for proliferative lupus nephritisGabriel Contreras, Victoriano Pardo, Baudouin Leclercq, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2018
Effect of Plasma Protein Binding on the Anti-Hepatitis B Virus Activity and Pharmacokinetic Properties of NVR 3-778Nicky Helsen, Tom Vervoort, Joris Vandenbossche, et al.
Angewandte Chemie (International Ed. in English)|December 11, 2008
Monitoring catalysis of the membrane-bound hydrogenase from Ralstonia eutropha H16 by surface-enhanced IR absorption spectroscopyNattawadee Wisitruangsakul, Oliver Lenz, Marcus Ludwig, et al.
Frontiers in Microbiology|May 16, 2022
High-Yield Production of Catalytically Active Regulatory [NiFe]-Hydrogenase From <i>Cupriavidus necator</i> in <i>Escherichia coli</i>Qin Fan, Giorgio Caserta, Christian Lorent, et al.
Pageof 25

Showing results (71-80 of 250) with videos related to

Sort By:
Pageof 25
Nature Human Behaviour|June 23, 2022
Large but diminishing effects of climate action nudges under rising costsSebastian Berger, Andreas Kilchenmann, Oliver Lenz, et al.
Journal of the American Chemical Society|October 31, 2025
NRVS Spectroscopy Resolves Distinct Bridging Hydride Intermediates in [NiFe]-HydrogenaseGiorgio Caserta, Konstantin Laun, Jean-Pierre Oudsen, et al.
FEBS Letters|August 3, 2005
A model system for [NiFe] hydrogenase maturation studies: Purification of an active site-containing hydrogenase large subunit without small subunitGordon Winter, Thorsten Buhrke, Oliver Lenz, et al.
The Journal of Biological Chemistry|November 8, 2008
Oxygen-tolerant H2 oxidation by membrane-bound [NiFe] hydrogenases of ralstonia species. Coping with low level H2 in airMarcus Ludwig, James A Cracknell, Kylie A Vincent, et al.
Journal of the American College of Surgeons|August 5, 2009
Secondary autogenous arteriovenous fistulas in the "fistula first" era: results of a longterm prospective studyLoay Salman, Manju Alex, Stephen W Unger, et al.
Journal of the American Chemical Society|February 4, 2015
Reversible active site sulfoxygenation can explain the oxygen tolerance of a NAD+-reducing [NiFe] hydrogenase and its unusual infrared spectroscopic propertiesMarius Horch, Lars Lauterbach, Maria Andrea Mroginski, et al.
The New England Journal of Medicine|March 5, 2004
Sequential therapies for proliferative lupus nephritisGabriel Contreras, Victoriano Pardo, Baudouin Leclercq, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2018
Effect of Plasma Protein Binding on the Anti-Hepatitis B Virus Activity and Pharmacokinetic Properties of NVR 3-778Nicky Helsen, Tom Vervoort, Joris Vandenbossche, et al.
Angewandte Chemie (International Ed. in English)|December 11, 2008
Monitoring catalysis of the membrane-bound hydrogenase from Ralstonia eutropha H16 by surface-enhanced IR absorption spectroscopyNattawadee Wisitruangsakul, Oliver Lenz, Marcus Ludwig, et al.
Frontiers in Microbiology|May 16, 2022
High-Yield Production of Catalytically Active Regulatory [NiFe]-Hydrogenase From <i>Cupriavidus necator</i> in <i>Escherichia coli</i>Qin Fan, Giorgio Caserta, Christian Lorent, et al.
Pageof 25